Investing in Codexis, Inc. (CDXS)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)6.7572
Intrinsic value (DCF)2.26-42
Graham-Dodd Method0.00-100
Graham Formula19.76404

Company description

Codexis Inc. (CDXS) is a biotechnology company that focuses on the development and commercialization of enzyme-based products for the healthcare and industrial markets. The company's proprietary technology platform, CodeEvolver, is used to create custom enzymes that can be utilized in various industries, including pharmaceuticals, food and beverage, and energy. CDXS has a strong track record of success, with several partnerships and collaborations with top pharmaceutical companies and government agencies. Their innovative approach to enzyme engineering has led to the creation of diverse and sustainable solutions that can help improve the efficiency of industries while reducing their environmental footprint. The company's dedication to innovation and sustainability has made them a leader in the biotechnology industry, with a growing global presence and a promising future ahead.